Eurofins GeneScan announces the hiring of Lulu Kurman in the position of Manager of Food Safety Systems. Ms. Kurman will have oversight of the food safety, traceability and vendor certification programs being offered by Eurofins GeneScan. She will also serve as liaison with Eurofins Certification in Paris for implementation of ISO-22000, BRC and GMP+ accreditation programs.
Ms Kurman, who will be based in New Jersey, did her baccalaureate work at Cornell University and received a Master’s degree in Nutritional Sciences from the University of Illinois. Her work experience has been in the areas of nutritional ingredients and labeling regulations. Most recently, as Regulatory Manager at McCormick and Company, her focus was on regulatory issues in the international marketplace including allergen and GMO labeling.
Eurofins GeneScan has been operating programs for the agro-food industry for traceability, Identity Preservation, channeling and supply chain management to control pesticides, GMOs, mycotoxin etc. and is expanding its services to encompass consulting and certification related to food and feed safety. Specifically, EGS will now offer guidance and certification according to globally recognized and relevant agro-food standards such as ISO 22000, IFS, BRC, and GMP+. Michael Russell, president of Eurofins GeneScan said “Lulu brings new areas of expertise to the company. Her experience related to food safety parameters will be especially useful to our consulting team as we continue to develop programs and services that help clients manage the many facets of their international supply chains to deliver safe, high-quality product in a cost efficient manner.”
Eurofins GeneScan Inc., located in Metairie, LA. is a subsidiary of the Eurofins Scientific, S.A. Eurofins-GeneScan operates in the area of quality and identity control of food and animal feed. The focus of these activities is the detection of allergens and detection of genetically modified organisms (GMO) in seeds, agricultural commodities, semi-finished and finished products.
The company meets its customers’ global requirements by operating its own analysis laboratories in Europe, North and South America and by establishing networks of strategic partners and licensees.
In addition to carrying out service analyses Eurofins-GeneScan also offers the corresponding diagnostics kits to third party laboratories. The Group’s portfolio also includes design, implementation and certification of customized control programs and identity preservation systems along the entire production chain.
Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors.
With over 3,500 staff in more than 70 laboratories across 17 countries, Eurofins offers a portfolio of over 10,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to provide its customers with high quality services, accurate results in time and, if requested, expert advice by our highly qualified staff.
The Eurofins Group is one of the global market leaders in this field of applied life sciences. It intends to pursue its dynamic growth strategy and expand both, its technology portfolio and its geographic reach. Through R&D, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international player in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on Euronext in the Paris (ISIN FR0000038259) and Frankfurt (WKN 910251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERSC FP, ESF, EUFI.DE).
This press release might contain forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of the companies involved as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. All parties disclaim any intent or obligation to update any of these forward-looking statements.